About Us  |  Contact Us  |  Feedback  |  Portfolio  |  Press  |  Advertise  |  Careers  |  Sitemap 
Medindia
   
   Google Search   Advanced Search
Web Medindia   
Health News RSSHealth news
Disease News RSSDisease News
SubscribeSubscribe
Login
Password
Forgot Password   New User
Medindia On MobileMedindia On Mobile Buy Health ProductsBuy Health Products
Medindia » Latest Health News » Cervarix: a Promising Experimental Vaccine for HPV Cleared for Sale
Latest Headlines
Britney's Parents Put Her Under Six Month Sex Ban (3 hrs ago)
Amy Winehouse On Watch After Suicide Attempt (3 hrs ago)
Soon, a Magic Polypill for Heart Problems (3 hrs ago)
Human Diseases can Be Studied by Mounting Mini Microscopes on the Heads of Mice (3 hrs ago)
Energy Supply to the Brain During Fasting is Derived from Muscle (4 hrs ago)
Crohn's Disease may Be Caused by Disabled Immune Gut Cells (4 hrs ago)
Many Young Britons Feel Their Parents Have Taken Drugs (4 hrs ago)
All Latest News
News - Quick Links
News Central
Latest Health News
News Category
Popular News
Health News and Press Release
Special Reports
Health Watch
Health In Focus
Breaking Health News
Celebrating Life
Medindia - Exclusive
India Special
Lifestyle and Wellness
Popular News Topics
Drug News    Subscribe
Posted online: Tuesday, September 25, 2007 at 7:07:34 PM
Font Size
More News on: Cervical Cancer

Cervarix: a Promising Experimental Vaccine for HPV Cleared for Sale

GlaxoSmithKline on Monday announced that the European Commission has approved the company's experimental human papillomavirus vaccine Cervarix for sale and marketing in the European Union, Reuters reports. Cervarix has been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.



According to a recent study, Cervarix was 90.4% effective in preventing lesions caused by HPV strains 16 and 18, based on an analysis that only required detection of the virus in the lesions. However, researchers found most of the lesions contained multiple HPV strains known to cause cancer, and GSK said the data showed Cervarix was 100% effective in preventing lesions caused by strains 16 and 18.

According to the study, the vaccine also provided significant protection against HPV strains 31, 45 and 52, which together account for about 12% of cervical cancer cases.

The European Committee for Human Medicinal Products in July recommended Cervarix for sale and marketing in the European Union. The committee reviewed data on the vaccine from clinical trials involving 30,000 women. A GSK spokesperson said Cervarix would go on sale in major European markets shortly. She added, "We intend to launch across Europe within the next few weeks."

GSK declined to comment on how much the company will charge for Cervarix or whether the European price would be above or below that in Australia, where the vaccine received regulatory approval in May. The vaccine is not likely to go on sale in the U.S. before 2008, Reuters reports. The company said a decision on its FDA application for Cervarix's approval in the U.S. will be given in January 2008.
Page 1 Page 1 | 2  Next

 Related Links
Medindia on Cervical Cancer - Overview
Cervical cancer is a slowly progressing disease, which affects the lining of the mouth of the uterus, known as cervix

Read More...

For More Information
FDA Grants Standard Review for GSK's Experimental HPV Vaccine Cervarix
New Cervical Cancer Vaccine Targets Women Over 30
World's First Cervical Cancer Vaccine to go on Sale
 
 Share this News:
Digg It
Digg
Del.icio.us
Del.icio.us
Stumbleupon
StumbleUpon
Google
Google
Windows Live
Windows Live
NewsVine
Newsvine
Reddit
Reddit
Post Your Comments

Be the first to comment

* Name :
* Comment :
* Your comment can be maximum of 1000 characters
* Email :
* Your Email address will not be displayed on the site or used to send unsolicited e-mails.
* Country :
           
Drug Related News
Soon, a Magic Polypill for Heart Problems
New Vaccine for Anti-tumour Shows Promising Results in Mice
Patients can Be Saved Even 4.5 Hrs After Stroke by Blood Thinning Drug
Potential sources of bias in medical stories ignored by media
Blood Thinning Drug Linked to Increased Risk of Bleeding in Brain
Read More

 News Archive

 Search by Keyword


Web Medindia  Advanced Search
Feedback
Last Updated - - Designed & Content Managed by Medindia Health Network Pvt Ltd. Hosted & Technical Support by FrontPoint Systems
DisclaimerThe contents of this site are for informational purposes only. Always seek the advice of a qualified physician for any doubts.
To Read full Disclaimer Click Here!
Best viewed with resolution 1024x768 px.
Advertise with us |  Medindia Copyright |  Privacy Policy |  © All Rights Reserved 1997 - 2008